| For: | Santos GL, dos Santos CF, Rocha GR, Calmon MS, Lemos FF, Silva LG, Luz MS, Pinheiro SL, Botelho AC, de Melo FF. Beyond glycemic control: Roles for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists in diabetic kidney disease. World J Diabetes 2025; 16(6): 104706 [PMID: 40548289 DOI: 10.4239/wjd.v16.i6.104706] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v16/i6/104706.htm |
| Number | Citing Articles |
| 1 |
Indumathi Singh, Ann M. Poynten, Arun V. Krishnan, Mark D.P. Willcox, Maria Markoulli. The ocular surface in type 2 diabetes: pathophysiology and impact of anti-diabetic drugs. Progress in Retinal and Eye Research 2026; 110 doi: 10.1016/j.preteyeres.2025.101417
|
| 2 |
Yanling Huang, Jiping Shen, Rulian Liang, Jinyuan Zhao, Wenjun Lin, Xianfeng Wu. UACR as a clinical predictor of incident osteoarthritis: prospective evidence from the UK Biobank. Clinical Rheumatology 2026; doi: 10.1007/s10067-026-08396-1
|
| 3 |
Seok Won Chung, Jong Pil Yoon, Sung-Jin Park. Inhibiting muscle degeneration in rotator cuff tears: integrative biologic approaches targeting regeneration, fibrosis, and metabolism. Stem Cells Translational Medicine 2026; 15(6) doi: 10.1093/stcltm/szag023
|
| 4 |
Sonia Rațiu, Mihaela I. Mariș, Adina V. Furdui-Lința, Laurențiu V. Sima, Tiberiu I. Bratu, Adrian Sturza, Danina M. Muntean, Octavian M. Crețu. Oxidative Stress in the Pathophysiology of Chronic Venous Disease: An Overview. Antioxidants 2025; 14(8) doi: 10.3390/antiox14080989
|
| 5 |
Karim Bitar, Jad Abdul Khalek, Rana Zareef, Fadi Bitar, Mariam Arabi. Dapagliflozin: Potential Role in Pediatric Cardiac Patient Care. Cardiology in Review 2026; doi: 10.1097/CRD.0000000000001290
|
| 6 |
Fen Li, Ruyi Zhong, Qing Qiu. From pathogenic carriers to therapeutic hope: the dual role and translational prospects of exosomes in diabetic kidney disease. Frontiers in Endocrinology 2026; 17 doi: 10.3389/fendo.2026.1831272
|
| 7 |
Brigida S, Arul Amutha Elizabeth, Soujania Singh, Monica N, Tanuja Lella. Comparative Effectiveness and Reliability of SGLT2 Inhibitors with Metformin in patients with Inadequate control of NIDDM. Research Journal of Pharmacy and Technology 2026; 19(10) doi: 10.52711/0974-360X.2026.00651
|